Maria Wiese
Goettingen, NI, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Pediatric high-grade gliomas in patients with neurofibromatosis type 1-A collaborative cohort study from the SIOPE HGG/DIPG working group.
Journal: Neuro-oncology practice
Published: May 28, 2025
Treatment-related survival patterns in diffuse intrinsic pontine glioma using a historical cohort: A report from the European Society for Pediatric Oncology DIPG/DMG Registry.
Journal: Neuro-oncology advances
Published: November 25, 2024
MSH2, MSH6, MLH1, and PMS2 immunohistochemistry as highly sensitive screening method for DNA mismatch repair deficiency syndromes in pediatric high-grade glioma.
Journal: Acta neuropathologica
Published: November 13, 2024
RNF40 epigenetically modulates glycolysis to support the aggressiveness of basal-like breast cancer.
RNF40 epigenetically modulates glycolysis to support the aggressiveness of basal-like breast cancer.
Journal: Cell death & disease
Published: December 05, 2022
Boswellic acid formulations are not suitable for treatment of pediatric high-grade glioma due to tumor promoting potential.
Journal: Journal of traditional and complementary medicine
Published: November 01, 2022
Pediatric high-grade gliomas and the WHO CNS Tumor Classification-Perspectives of pediatric neuro-oncologists and neuropathologists in light of recent updates.
Journal: Neuro-oncology advances
Published: June 23, 2022
Transitioning to molecular diagnostics in pediatric high-grade glioma: experiences with the 2016 WHO classification of CNS tumors.
Journal: Neuro-oncology advances
Published: October 01, 2021
Complementary and alternative medicine in children with diffuse intrinsic pontine glioma-A SIOPE DIPG Network and Registry study.
Journal: Pediatric blood & cancer
Published: March 02, 2021
Decreased PRC2 activity supports the survival of basal-like breast cancer cells to cytotoxic treatments.
Journal: Cell death & disease
Published: February 15, 2021
Combined treatment with CBP and BET inhibitors reverses inadvertent activation of detrimental super enhancer programs in DIPG cells.
Journal: Cell death & disease
Published: December 02, 2019
Last Updated: 09/26/2026